Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT02715843
What this trial is testing

Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
Molecular Templates, Inc.
Testing effectiveness (Phase 2)Study completedNCT01686321
What this trial is testing

Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma

Who this might be right for
Aggressive Lymphoma
University of Göttingen 68
Post-approval studies (Phase 4)UnknownNCT05828147
What this trial is testing

Anti-CD20 Antibodies for Treatment of SLE-PAH

Who this might be right for
Systemic Lupus ErythematosusPulmonary Arterial Hypertension
Chinese SLE Treatment And Research Group 50
Testing effectiveness (Phase 2)Study completedNCT01647971
What this trial is testing

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins LymphomaB-cell LymphomaWaldenstrom's Macroglobulinemia+4 more
TG Therapeutics, Inc. 39
Early research (Phase 1)UnknownNCT04215016
What this trial is testing

Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Relapsed or Refractory DLBCL Patients With Either CD19 or CD20 Positive
Fujian Medical University 18
Testing effectiveness (Phase 2)Study completedNCT00006436
What this trial is testing

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Who this might be right for
Lymphoma, AIDS-relatedLymphoma, Large B-Cell, Diffuse
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Study completedNCT00576758
What this trial is testing

GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 175
Large-scale testing (Phase 3)Not Yet RecruitingNCT07765914
What this trial is testing

Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Children's Hospital of Fudan University 120
Testing effectiveness (Phase 2)Ended earlyNCT00088881
What this trial is testing

Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+5 more
National Cancer Institute (NCI) 62
Not applicableUnknownNCT05258136
What this trial is testing

Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

Who this might be right for
PTLDCAEBVHLH
Beijing Friendship Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05421663
What this trial is testing

JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellLymphoma, Large B-Cell, Diffuse
Janssen Research & Development, LLC 166
Large-scale testing (Phase 3)UnknownNCT00028717
What this trial is testing

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 400
Not applicableStudy completedNCT06654817
What this trial is testing

Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris

Who this might be right for
PemphigusPemphigus Vulgaris (PV)
Chao Ji 38
Testing effectiveness (Phase 2)Study completedNCT00071396
What this trial is testing

Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)WithdrawnNCT06935474
What this trial is testing

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Who this might be right for
Lupus Nephritis (LN)
AbelZeta Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00250861
What this trial is testing

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
US Oncology Research 110
Large-scale testing (Phase 3)Ended earlyNCT00486759
What this trial is testing

Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 787
Post-approval studies (Phase 4)Study completedNCT01358253
What this trial is testing

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Ruijin Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00394836
What this trial is testing

HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab

Who this might be right for
Lymphoma, Follicular
GlaxoSmithKline 116
Next Page